SHEFFIELD, United Kingdom, Jan. 8, 2025 /PRNewswire/ -- BlackfinBio Ltd (BFB) a clinical stage gene therapy company focused on the development of treatments for rare neurological diseases has announced today that it has acquired the Parkinson's patent portfolio from OXB. BlackfinBio Ltd...
Read More Details
Finally We wish PressBee provided you with enough information of ( BlackfinBio Ltd announces the acquisition of Parkinson's IP patent portfolio from OXB )
Also on site :
- Bitcoin Closes Month at $107K, Analyst Sees 9% Surge on Horizon
- Huawei Named a Challenger in Gartner® Magic Quadrant™ for Backup and Data Protection Platforms
- China's June factory activity unexpectedly expands, private survey shows